KLRA
KLRA Stock
KLRA (KLRA) stock.
KLRA insider trading activity (SEC Form 4)
Sentiment
50/100
Buys (3m)
0
Sells (3m)
0
Net (3m)
$0
ContextInstitutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 8, 2026 | Tregoning Kathleenofficer: See Remarks | Grant | 175,000 | $23.30 |
| Jun 11, 2026 | Renaud Ronald C JRdirector, officer: CEO & President | Option | 38,094 | $5.25 |
| Apr 22, 2026 | RTW INVESTMENTS, LP10 percent owner | Buy | 500,000 | $16.00 |
| Apr 20, 2026 | Bain Capital Life Sciences Investors, LLC10 percent owner | Buy | 1,562,500 | $16.00 |
| Apr 20, 2026 | Kaplan Andrew T.director, 10 percent owner: | Buy | 8,398,438 | $16.00 |
| Apr 20, 2026 | Kaplan Andrew T.director, 10 percent owner: | Grant | 38,300 | $16.00 |
| Apr 20, 2026 | Cloghessy Paulaofficer: Chief People Officer | Grant | 60,000 | $16.00 |
| Apr 20, 2026 | Akamine Scottofficer: Chief Legal Officer | Grant | 60,000 | $16.00 |
| Apr 20, 2026 | Renaud Ronald C JRdirector, officer: CEO & President | Grant | 300,000 | $16.00 |
| Apr 20, 2026 | Burgess Paul D.officer: See Remarks | Grant | 100,000 | $16.00 |
| Apr 20, 2026 | BAIN CAPITAL INVESTORS LLC10 percent owner | Buy | 8,398,438 | $16.00 |
| Apr 20, 2026 | Coleman Jamie Bethofficer: Chief Commercial Officer | Grant | 75,000 | $16.00 |
| Apr 20, 2026 | MACKAY MARTINdirector | Grant | 38,300 | $16.00 |
| Apr 20, 2026 | Wasserman Scott M.officer: Chief Medical Officer | Grant | 100,000 | $16.00 |
| Apr 20, 2026 | Hite Christopherdirector | Grant | 38,300 | $16.00 |
Source: KLRA SEC Form 4 filings, latest Jul 8, 2026. For informational purposes only — not investment advice.
See the full KLRA insider & 13F page →Track KLRA with Drillr
SEC filings, earnings calls, insider activity, alt-data signals — all queryable through Drillr's AI terminal and MCP API.
Try Drillr for free